Just read (again) the cancer antigen discovery paper by CureVac's bioinformatics group. Using complementary Oxford Nanopore sequencing in addition to the Illumina RNA- and DNA-Seq brings up new and different potential antigens, in contrast to using TCGA/GTEx alone.
doi.org/10.1158/2326...